Kim RB - Search Results

1

Toward a personalized medicine approach to the management of inflammatory bowel disease.

Mosli MH, Sandborn WJ, Kim RB, Khanna R, Al-Judaibi B, Feagan BG. Mosli MH, et al. Among authors: kim rb. Am J Gastroenterol. 2014 Jul;109(7):994-1004. doi: 10.1038/ajg.2014.110. Epub 2014 May 20. Am J Gastroenterol. 2014. PMID: 24842338 Review.

2

Sunny outlook for personalized medicine: tamoxifen and beyond.

Teft WA, Kim RB. Teft WA, et al. Among authors: kim rb. Pharmacogenomics. 2013 Oct;14(13):1533-6. doi: 10.2217/pgs.13.130. Pharmacogenomics. 2013. PMID: 24088122 No abstract available.

3

Is personalized medicine a dream or a reality?

Morse BL, Kim RB. Morse BL, et al. Among authors: kim rb. Crit Rev Clin Lab Sci. 2015 Feb;52(1):1-11. doi: 10.3109/10408363.2014.950407. Epub 2014 Sep 2. Crit Rev Clin Lab Sci. 2015. PMID: 25181036

4

Genetic Predictors of Azathioprine Toxicity and Clinical Response in Patients with Inflammatory Bowel Disease.

Al-Judaibi B, Schwarz UI, Huda N, Dresser GK, Gregor JC, Ponich T, Chande N, Mosli M, Kim RB. Al-Judaibi B, et al. Among authors: kim rb. J Popul Ther Clin Pharmacol. 2016;23(1):e26-36. Epub 2016 Feb 22. J Popul Ther Clin Pharmacol. 2016. PMID: 26950049

5

HLA-DQA1-HLA-DRB1 polymorphism is a major predictor of azathioprine-induced pancreatitis in patients with inflammatory bowel disease.

Wilson A, Jansen LE, Rose RV, Gregor JC, Ponich T, Chande N, Khanna R, Yan B, Jairath V, Khanna N, Sey M, Beaton M, McIntosh K, Teft WA, Kim RB. Wilson A, et al. Among authors: kim rb. Aliment Pharmacol Ther. 2018 Mar;47(5):615-620. doi: 10.1111/apt.14483. Epub 2017 Dec 22. Aliment Pharmacol Ther. 2018. PMID: 29270995

6

Apixaban and Rosuvas--tatin Pharmacokinetics in Nonalcoholic Fatty Liver Disease.

Tirona RG, Kassam Z, Strapp R, Ramu M, Zhu C, Liu M, Schwarz UI, Kim RB, Al-Judaibi B, Beaton MD. Tirona RG, et al. Among authors: kim rb. Drug Metab Dispos. 2018 May;46(5):485-492. doi: 10.1124/dmd.117.079624. Epub 2018 Feb 22. Drug Metab Dispos. 2018. PMID: 29472495

7

Letter: predicting azathioprine-associated pancreatitis in IBD-phenotype or genotype? Authors' reply.

Wilson A, Jansen LE, Rose RV, Gregor JC, Ponich T, Chande N, Khanna R, Yan B, Jairath V, Khanna N, Sey M, Beaton M, McIntosh K, Teft WA, Kim RB. Wilson A, et al. Among authors: kim rb. Aliment Pharmacol Ther. 2018 Apr;47(7):1044-1045. doi: 10.1111/apt.14562. Aliment Pharmacol Ther. 2018. PMID: 29512906 No abstract available.

8

HLADQA1*05 genotype predicts anti-drug antibody formation and loss of response during infliximab therapy for inflammatory bowel disease.

Wilson A, Peel C, Wang Q, Pananos AD, Kim RB. Wilson A, et al. Among authors: kim rb. Aliment Pharmacol Ther. 2020 Feb;51(3):356-363. doi: 10.1111/apt.15563. Epub 2019 Oct 25. Aliment Pharmacol Ther. 2020. PMID: 31650614

9

High infliximab trough concentrations are associated with sustained histologic remission in inflammatory bowel disease: a prospective cohort study.

Wilson A, Choi B, Sey M, Ponich T, Beaton M, Kim RB. Wilson A, et al. Among authors: kim rb. BMC Gastroenterol. 2021 Feb 18;21(1):77. doi: 10.1186/s12876-021-01650-7. BMC Gastroenterol. 2021. PMID: 33602145 Free PMC article.

10

Pretreatment HLADQA1-HLADRB1 Testing for the Prevention of Azathioprine-Induced Pancreatitis in Inflammatory Bowel Disease: A Prospective Cohort Study.

Wilson A, Wang Q, Choi YH, Ponich T, Gregor JC, Chande N, Yan B, Sey M, Beaton M, Kim RB. Wilson A, et al. Among authors: kim rb. Clin Transl Gastroenterol. 2021 Apr 5;12(4):e00332. doi: 10.14309/ctg.0000000000000332. Clin Transl Gastroenterol. 2021. PMID: 33821842 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

419 results

Search Page

Filters